Referencias

1. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. Prevalence of Autism in a US Metropolitan Area. Journal of the American Medical Association, 2003: 289 (1): 49-55.



2. Yeargin-Allsopp M. Past and future perspectives in autism epidemiology. Molecular Psychiatry, 2002; 7: S9-S11.



3. Children's Health Act of 2000, Public Law 106-10.



4. http://www.nimh.nih.gov/autismiacc/nihacc.cfm



5. http://www.nimh.nih.gov/autismiacc/other.cfm



6. http://www.nimh.nih.gov/autismiacc/other.cfm



7. http://www.nimh.nih.gov/press/prautismcenters.cfm



8. http://www.nimh.nih.gov/autismiacc/staart.cfm



9. Benes F. A national resource for postmortem brain research. Grant No. IR24MH068855-01. In progress.



10. Lord C. Training/research diagnosis/autism spectrum disorders. Grant No. 5R25MH067723-01. In progress.



11. Lord C. Validity of diagnostic measures for autism spectrum. Grant No. 5R01MH066496-02. In progress.



12. Stone WL, Coonrod EE, Ousley OY. Screening tool for autism in two-year-olds (STAT): development and preliminary data. Journal of Autism and Developmental Disorders, 2000; 30(6): 607-12.



13. Ozonoff S. Infants at risk of autism: a longitudinal study. Grant No. 1R01MH068398-01. In progress.



14. Landa R. Early detection, intervention and neurobiology in autism. Grant No. 1U54MH066417-01A10002. In progress.



15. Sigman M. Infants at risk of autism: a longitudinal study. Grant No. 1U54MH068172-010001. In progress.



16. Pediatric Study Centers (PSC) for a MRI Study of Normal Brain Development. http://grants.nih.gov/grants/guide/notice-files/not98-114.html



17. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, Paus T, Evans AC, Rapoport JL. Brain development during childhood and adolescence: a longitudinal MRI study. Nature Neuroscience, 1999; 2(10): 861-63.



18. Rapoport JL, Giedd JN, Blumenthal J, Hamburger S, Jeffries N, Fernandez T, Nicolson R, Bedwell J, Lenane M, Zijendos A, Paus T, Evans A. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Archives of General Psychiatry, 1999; 56(7): 649-54.



19. Martin A, Giedd J. Brain imaging of childhood onset psychiatric disorders, endocrine disorders and healthy controls. NIH Protocol No. 89-M-0006. In progress. http://clinicalstudies.info.nih.gov/cgi/wais/bold032001.pl?A_1989-M-0006.html@autism



20. Martin A, Weisberg J. Neural foundations for understanding social and mechanical concepts, Cognitive Neuropsychopharmacology. 2003, 20 (3/4/5/6): 575-87.



21. Courchesne E. Anatomy and function correlates of cognition in autism. Grant No. 5R01MH36840-18. In progress.



22. Piven J. Brain development in developmental disorders. Grant No. 5R01MH061696-05. In progress.



23. Reiss AL. Longitudinal MRI study of brain development in Fragile X. Grant No. 5R01MH064708-02. In progress.



24. Piven J. Longitudinal MRI study of brain development in Fragile X, 5. Grant No. 5R01MH064580-02. In progress.



25. Bachevalier J. Development of medial temporal lobe functions. Grant No. R01MH58846-03. In progress.



26. Bachevalier J, Malkova L, Mishkin M. Effects of selective neonatal temporal lobe lesions on socioemotional behavior in infant rhesus monkeys. Behavioral Neuroscience, 2001, 115 (3): 545-59.



27. Piven J, Palmer P, Jacobi D, Childress D, Arndt S. Broader autism phenotype: evidence from a family history study of multiple-incidence autism families. American Journal of Psychiatry, 1997; 154(2): 185-90.



28. Piven J. Gene-brain-behavior relationships in Autism. Grant No. 5U54MH066418-02. In progress.



29. International Molecular Genetic Study of Autism Consortium. A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. American Journal of Human Genetics, 2001, 69: 570-81.



30. Liu J, Nyholt D, Magnussen P, Parano E, Pavone P, Geschwind D, Lord C, Iversen P, Hoh J. the Autism Genetic Resource Exchange Consortium, Ott J, Gilliam C. A genomewide screen for autism susceptibility loci. American Journal of Human Genetics, 2001, 69: 327-40.



31. Wassink TH, Piven J, Vieland VJ, Huang J, Swiderski RE, Pietila J, Braun T, Beck G, Folstein SE, Haines JL, Sheffield VC. Evidence supporting WNT2 as an autism susceptibility gene. American Journal of Medical Genetics, May 17, 2001.



32. Yonan AL, Alarcon M, Cheng R, Magnusson PKE, Spence SJ, Palmer AA, Grunn A, Juo SHH, Terwilliger J, Liu J, Cantor RM, Geschwind DH, Gilliam TC. A genomewide screen of 345 families for autism-susceptibility loci. American Journal of Human Genetics, 73: 886-97, 2003. http://www3.interscience.wiley.com/cgi-bin/issuetoc?ID=77002064



33. Geschwind D. Genomewide search autism susceptibility loci supplement. Grant No. 3R01MH064547-02S1. In progress.



34. Brzustowicz L. Genetic Components of Autism Spectrum Disorders. Grant No. 1R01MH070366-01. In progress.



35. Leighton PA, Mitchell KJ, Goodrich LV, Lu X, Pinson K, Scherz P, Skarnes WC, Tessier-Lavigne M. Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature, 2001; 410(6825): 174-79.



36. Giger RJ, Cloutier JF, Sahay A, Prinjha RK, Levengood DV, Moore SE, Pickering S, Simmons D, Rastan S, Walsh FS, Kolodkin AL, Ginty DD, Geppert M. Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron, 2000; 25(1): 29-41.



37. Akshoomoff N, Pierce K, Courchesne E. The Neurobiological basis of autism from a developmental perspective. Development and Psychopathology, 2002, 14: 613-634.



38. Courchesne E, Carper R, Akshoomoff N. Evidence of Brain Overgrowth in the first year of life in autism. JAMA, 2003, 290(3): 337-344.



39. Griffith EM, Pennington BF, Wehner EA, Rogers SJ. Executive Functions in Young Children with Autism. Child Development, l999, 70 (4): 817-832.



40. Volkmar F. The Social Neuroscience of Autism and Related Disorders. Grant No. 5U54MH066494-02. In progress.



41. Miyashiro KY, Beckel-Mitchener A, Becker KG, Barret T, Liu L, Carbonetto S, Weiler IJ, Greenough WT, Eberwine J. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron, 2003, 37(3): 417-431.



42. Bristol MM, Cohen DJ, Costello EJ, Denckla M, Eckberg TJ, Kallen R, Kraemer HC, Lord C, Maurer R, McIlvane WJ, Minshew N, Sigman M, Spence MA. State of the science in autism: report to the National Institutes Health. Journal of Autism and Developmental Disorders, 1996; 26(2): 121-54.



43. Greenhill LL, Vitiello B, Abikoff H, Levine J, March JS, Riddle MA, Capasso L, Cooper TB, Davies M, Fisher P, Findling RL, Fried J, Labellarte MJ, McCracken JT, McMahon D, Robinson J, Skrobala A, Scahill L, Varipatis E, Walkup JT, Zito JM. Developing methodologies for monitoring long-term safety of psychotropic medications in children: Report on the NIMH conference, September 25, 2000. Journal of the American Academy of Child & Adolescent Psychiatry, 2003; 42(6): 625-26.



44. McDougle CJ, Scahill L, McCracken JT, Aman MG, Tierney E, Arnold E, Freeman BJ, Marin A, McGough JJ, Cronin P, Posey DJ, Riddle MA, Ritz L, Swiezy NB, Vitiello B, Bolkmar FR, Botolato NA, Walson P. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network: Background and rationale for an initial controlled study of risperidone, Child & Adolescent Psychiatric Clinics of North America, 2000; 9(1): 201-24.



45. Arnold LE, Aman MG, Martin A, Collier-Crespin A, Vitiello B, Tierney E, Asarnow R, Bell-Bradshaw F, Freeman BJ, Gates-Ulanet P, Klin A, McCracken JT, McDougle CJ, McGough JJ, Posey DJ, Scahill L, Swiezy NB, Ritz L, Volkmar F. Assessment in multisite randomized clinical trials of patients with autistic disorder: The Autism RUPP Network. Journal of Autism & Developmental Disorders, 2000; 30(2): 99-111.



46. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold E, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D. Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 2002; 347(5): 314-21.



47. Aman, M. The OSU RUPP-PI Project. Grant No. U10MH66768. In progress.



48. McDougle, C. RUPP-PI at Indiana University School of Medicine. Grant No. U10MH66766. In progress.



49. Scahill, L. RUPP-PI Program at Yale University. Grant No. U10MH66764. In progress.



50. Koegel LK, Koegel RL, Jarrower JK, Carter CM. Pivotal response intervention I: Overview of approach. Journal of the Association for the Severely Handicapped, 1999; 24: 174-85.



51. Koegel LK, Koegel RL, Shoshan Y, McNerney E. Pivotal response intervention II: Preliminary long-term outcome data. Journal of the Association for Persons with Severe Handicaps, 1999; 24:186-98.



52. Koegel RL, Brookman L, Koegel LK. Autism: Pivotal response intervention and parent empowerment. Trends in Evidence-Based Neuropsychiatry, 2003; 5(1): 53-61.



53. Koegel R. Research in autism: Parent intervention. Grant No. R10MH28210-22. In progress.



54. Schreibman L. Research in autism: Parent Intervention. Grant No. R10MH39434-14. In progress.



55. Whalen C, Schreibman L. Joint attention training for children with autism using behaviour modification procedures. The Journal of Child Psychology and Psychiatry, 2003; 44, 456-468.



56. Development of innovative treatment approaches to autism. http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-01-010.html